T
ech
CN
library_books
Mobile
library_books
Laptop/Pc
library_books
Smart Home
library_books
Audio
library_books
Games
Lastnews
Topics
Trending
News
Best Pick
Reviews
How To Do
Search ...
Repeat: Thunder Bridge Capital Partners IV, Inc. Announces Effectiveness of Registration Statement and Special Meeting Date for Proposed Business Combination with Coincheck, Inc.
...
The Sanborn Map Company, Inc. Receives Certification to ISO 9001:2015 Standard
...
Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition
...
Berman Tabacco Announces Investigation of Evolv Technologies Holdings, Inc. (EVLV, EVLVW) Concerning Accounting Practices
...
Dark Horse Consulting Group Acquires BioTechLogic, Inc.
...
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical stage RXR agonist for treatment of normal aging-related neurodegeneration, at the FASEB Science Research Conference on Cellular and Molecular Mechanisms of Brai
...
Music Licensing, Inc. (OTC: SONG) Announces Acquisition of Royalty Rights to "Thank God I Got It" by Desiigner, Bolstering Its Diverse and Star-Studded Portfolio
...
Olaplex Holdings, Inc. Announces Participation in the Barclays 17th Annual Global Consumer Staples Conference on September 4th
...
Matmerize, Inc., Introduces “ASKPOLY” – A Language Model Based Polymer Expert
...
Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis
...
1
2
3
4
5
6
7
8
9
10
...
38
menu
TechCN
person
menu